Several people have died, and the WHO is now investigating suspected human-to-human transmission of the dreaded hantavirus. Meanwhile, documents show that one of the world’s most controversial pharmaceutical giants began developing an mRNA vaccine against the virus as early as 2024—long before the latest alarms were raised.
It was in July 2024 that the pharmaceutical company Moderna announced a collaboration with Korea University College of Medicine to develop an mRNA-based vaccine against hantavirus.
This article is part of our exclusive premium content
- For Frihetsnytt subscribers only.
At Frihetsnytt, we rely entirely on you, our readers. Without government subsidies, without major advertisers, and without political agendas, we can uncover the facts, hold those in power accountable, and tell the truth—just as it is. Join our community today and get immediate access to all locked articles, exclusive interviews, podcasts, and events.
Try it for 14 days completely free—no commitment. After that, starting at just 69 SEK/month (billed annually).
Together, we’re building Sweden’s strongest independent media company. Welcome!
